New “Trojan horse” obesity drug supercharges weight loss in early tests

Researchers have created a new obesity drug that uses GLP-1/GIP signals to target cells and enhance metabolism, outperforming existing treatments in mice by curbing appetite and improving blood sugar levels. The drug can be used at lower doses, potentially reducing side effects. It shows promise for effective weight loss.